Skip to Main Content
Services Talent Knowledge
Site Search
Menu

Events

September 20, 2017

Hatch-Waxman Litigation: The Evolving Legal and Regulatory Framework

Since the enactment of the Hatch-Waxman Act, significant alterations to the pharmaceutical industry have taken place, especially in the approval of generic drugs. Years before the approval of the Act, the Federal Food, Drug, and Cosmetic Act (FFDCA) has helped generic companies to get regulatory approval by filing an Abbreviated New Drug Application (ANDA). Nevertheless, only a few number of generic drug have successfully entered the market.

Since the approval of the Act, the number of generic drugs successfully reaching the market has remarkably increased. However, along with the remarkable upsurge in figures, risks and litigation threats arising from Hatch-Waxman have also increased.

Join a panel of key thought leaders and professionals assembled by The Knowledge Group in a LIVE Webcast as they bring the audience to a road beyond the basics of bringing or defending against Hatch-Waxman Litigation and as they delve into the in-depth analysis of the current trends and recent court rulings surrounding this significant topic. Speakers will also provide the audience with practical strategies in bringing out the best in these lawsuits in a rapidly evolving legal climate.

Key topics include:

Hatch-Waxman Act: Fundamentals

Litigation Trends and Pitfalls

Recent Court Decisions

Scope, Privileges and Limitations

Trends, Developments and What Lies Ahead in 2018

Subscribe

Click here to sign up for alerts, blog posts, and firm news.

Featured Media

Alerts

Attention Providers! OMIG Audit Update: New Settlement Flexibility at Lower Confidence Payment Restored and DME Protocol Released

Alerts

NYS Trial Court Holds: Animals Are Family Too

Alerts

Website Accessibility Lawsuits: Several "Tester" Plaintiffs—Victor Lopez, Myrna Driffin, Damon Jones, Tazinique Echols, and Ashley Bahena—Targeting Businesses in Recent Flurry of Lawsuits

Alerts

Website Accessibility Lawsuits: Several "Tester" Plaintiffs—Brian Flores Gerardo, Jonathan Drummond, Makeda Evans, Andre Campbell, and Zephyrin Victor—Targeting Businesses in Recent Flurry of Lawsuits

Alerts

New York State Executive Order Expands Pharmacist Authority to Administer COVID-19 Vaccines Without Prescription

Alerts

Federal Judge Halts DOE's Crackdown on Diversity Programs